Psoriasis Clinical Trials
Recruiting psoriasis studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat psoriasis. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting psoriasis studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting psoriasis trials
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Nailfold Capillaroscopic Changes in Psoriasis
Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Assessing Psoriasis Treatment Outcomes
Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis
A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
Evaluation the Topical Apremilast Nanoformulation in Treatment of Localized Plaque Psoriasis
Psoriasis Comorbidities at Hospital Calderón Guardia
Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
Methotrexate Versus Apremilast for Pruritus in Psoriasis
Impact of Hand Rub Placement on Patient Trust and Disease Stigma
An AI-Based Erythema Measurement System for Psoriasis Lesions
Sebum Metabolomics and Lipidomics for Clinical Applications
Cross-Sectional Study for an Ocular Imaging-Based Predictive Model of Inflammatory Skin Diseases Grounded in Traditional Chinese Medicine
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
Thera-Clean® Microbubbles System in Patients With Skin Diseases
Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
PALLAS Laser for Skin Diseases
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
Real-Life Evaluation of Guselkumab Dosing Interval Adjustments
SEquential Treatment of PSoriasis With Biologics
Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?
A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis
Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects
Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
Pathogenesis of Periodontal Disease in Individuals With Psoriasis
Is Monitoring Enhanced Auto-fluorescence Beneficial for the Precise Removal of Tissue From Psoriatic Lesions With Ablative Lasers?
Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Evaluation of IL 12B Genetic Polymorphism (rs3213094)
A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
Genetic Variation in TRAF3IP2 (rs13190932)
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
A Basket Trial of Vunakizumab in Inflammatory Skin Diseases
Psoriasis clinical trials — common questions
Are psoriasis clinical trials free to join?
Yes. Participating in a psoriasis clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a psoriasis clinical trial?
Each psoriasis study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a psoriasis trial near me?
Use the location controls above. We'll show recruiting psoriasis trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many psoriasis trials are recruiting right now?
We're currently tracking roughly 33 recruiting psoriasis trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.